Table 2. Number of Positive Test Results and Cancers Detected by MRI, Ultrasonography, and PSA testing.
Variable | MRI | Ultrasonography | PSA (≥3 ng/mL) | ||
---|---|---|---|---|---|
Score 3-5 | Score 4-5 | Score 3-5 | Score 4-5 | ||
Positive test result | 72 | 43 | 96 | 52 | 40 |
Biopsy result | |||||
Significant cancera | 14 | 11 | 9 | 4 | 7 |
Insignificant cancerb | 7 | 5 | 13 | 7 | 6 |
Benign | 44 | 22 | 63 | 35 | 23 |
Withdrewc | 7 | 5 | 11 | 6 | 4 |
Abbreviations: MRI, magnetic resonance imaging; PSA, prostate-specific antigen.
SI conversion factor: to convert PSA to micrograms per liter, multiply by 1.
Significant cancer is defined as a Gleason score of 3+4 or higher (International Society of Urological Pathology score ≥2) (primary histologic definition of clinical significance).
Insignificant cancer is defined as a Gleason score of 3+3 (International Society of Urological Pathology score of 1).
The number of men who withdrew after being advised to have a biopsy.